Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 8(5): e63497, 2013.
Article in English | MEDLINE | ID: mdl-23717435

ABSTRACT

Sepsis is characterized by a generalized inflammatory response and organ failure, associated with mitochondrial dysfunction. Hydrogen sulfide donor NaHS has anti-inflammatory properties, is able to reduce metabolism and can preserve mitochondrial morphology and function. Rats were challenged with live Streptococcus pneumonia or saline and infused with NaHS (36 µmol/kg/h) or vehicle. Lung and kidney injury markers were measured as well as mitochondrial function, viability and biogenesis. Infusion of NaHS reduced heart rate and body temperature, indicative of a hypo-metabolic state. NaHS infusion reduced sepsis-related lung and kidney injury, while host defense remained intact, as reflected by unchanged bacterial outgrowth. The reduction in organ injury was associated with a reversal of a fall in active oxidative phosphorylation with a concomitant decrease in ATP levels and ATP/ADP ratio. Preservation of mitochondrial respiration was associated with increased mitochondrial expression of α-tubulin and protein kinase C-ε, which acts as regulators of respiration. Mitochondrial damage was decreased by NaHS, as suggested by a reduction in mitochondrial DNA leakage in the lung. Also, NaHS treatment was associated with upregulation of peroxisome proliferator-activated receptor-γ coactivator 1α, with a subsequent increase in transcription of mitochondrial respiratory subunits. These findings indicate that NaHS reduces organ injury in pneumosepsis, possibly via preservation of oxidative phosphorylation and thereby ATP synthesis as well as by promoting mitochondrial biogenesis. Further studies on the involvement of mitochondria in sepsis are required.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Energy Metabolism , Lung Injury/prevention & control , Pneumonia, Pneumococcal/drug therapy , Sulfides/pharmacology , Animals , Anti-Inflammatory Agents/therapeutic use , Disease Models, Animal , Electron Transport Complex I/metabolism , Heart Rate/drug effects , Kidney/drug effects , Kidney/physiopathology , Liver/drug effects , Liver/metabolism , Lung Injury/metabolism , Lung Injury/microbiology , Mitochondria/metabolism , Mitochondrial Turnover/drug effects , Oxidation-Reduction , Pneumonia, Pneumococcal/metabolism , Pneumonia, Pneumococcal/physiopathology , Protein Kinase C-epsilon/metabolism , Rats , Rats, Sprague-Dawley , Sepsis , Sulfides/therapeutic use , Tubulin/metabolism , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...